Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2Phase 1/2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1 1

Status

Completed 602Terminated 173Active not recruiting 135Recruiting 124Unknown 73Withdrawn 68Not yet recruiting 24Suspended 2Enrolling by invitation 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 22Lymphoid 10Thoracic 9CNS 9Other hematologic neoplasm 8Genitourinary 8Sarcoma 7Head & Neck 5Dermatologic 5Breast 5Gynecologic 4Tumor-Agnostic 2Plasma cell 2Other solid neoplasm 2Myeloid 2Endocrine 1

Conditions

Multiple Myeloma 2

Interventions

daratumumab 2Dexamethasone 2selinexor 1pomalidomide 1carfilzomib 1Lenalidomide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Plasma cell × Clear all
NCT06348147 2026-05-04

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

UNC Lineberger Comprehensive Cancer Center

Phase 2 Suspended
39 enrolled
Plasma cell

Multiple Myeloma

NCT04661137 2026-02-10

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Hackensack Meridian Health

Phase 2 Suspended
96 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡